HEMATOLOGY TRAINING

血液学培训

基本信息

  • 批准号:
    10445238
  • 负责人:
  • 金额:
    $ 73.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1975
  • 资助国家:
    美国
  • 起止时间:
    1975-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY / ABSTRACT The Hematology Research Training Program at the University of Washington is designed to provide intensive post-doctoral research training in investigative hematology. Although the program emphasizes cell and molecular biology, and has well-established strengths in stem cells, hematopoiesis, cell and gene therapy, platelets and hemostasis, the pathogenesis of hematologic malignancies, and hematopoietic cell transplantation; clinical research and outcomes investigation are also supported and encouraged. Program faculty include established investigators with strong independent research programs from both basic science and clinical departments of the University of Washington. The faculty is based at the University of Washington campuses, the Fred Hutchinson Cancer Research Center, BloodWorks NW, Harborview Medical Center, the VA Puget Sound Health Care System, and Seattle Children's Hospital Research Institute. The goal of the training program is to develop the research, presentation, and grant-writing skills that trainees will need to establish independent research careers, and to train future leaders in research hematology. Trainees have MD, MD/PhD or PhD degrees. Many have completed clinical fellowship training in hematology, but others are basic researchers wishing to work in the field. Trainees are chosen through an application process and interviews with program faculty. They obtain research experience by working with a mentor, and gain skills in laboratory and/or clinical investigation, data analysis, publishing papers, presentation, and acquiring independent grant support. Bidirectional translational projects (bench to bedside and bedside to bench) are encouraged. Trainees typically receive two years of funding from the T32 program, but often continue their training longer under separate funding mechanisms, including K12, K23, K08 or K99R00 grants and foundation support. Training progress is monitored by the faculty mentor, a separate faculty advisor, the Program Directors, and the Division of Hematology faculty through regular research presentations, meetings with each trainee, and written evaluations. Each six months, trainees update their individual development plan (IDP) and formally present their research progress and career goals to a Research Oversight Committee (ROC) consisting of the trainee's mentors and the T32 PI. 100% and 83% of trainees who completed our program over the past 5 and 10 years, respectively, have academic medicine or industry research careers. Strengths of the program include: the diverse research opportunities, a qualified prominent senior faculty, the inclusion and mentorship of talented junior faculty, the structured mentorship of trainees, the inclusion of under-represented minority trainees, strong and varied didactic sessions, and a long track record spanning over five decades of training graduates that subsequently obtain academic (or industry) research positions and become independent, distinguished investigators and thought-leaders throughout hematology.
项目摘要 /摘要 华盛顿大学的血液学研究培训计划旨在提供密集型 研究后血液学研究培训。尽管该程序强调细胞和分子 生物学,并且在干细胞,造血,细胞和基因疗法,血小板和血小板中具有良好的优势 止血,血液系统恶性肿瘤的发病机理和造血细胞移植;临床 研究和结果调查也得到了支持和鼓励。课程教师包括已建立的 来自基础科学和临床部门的强大独立研究计划的研究人员 华盛顿大学。该教师位于华盛顿大学校园,弗雷德 Hutchinson癌症研究中心,Bloodworks NW,Harbourview Medical Center,VA Puget Sound Health 护理系统和西雅图儿童医院研究所。培训计划的目标是发展 受训者需要建立独立研究的研究,演示和赠款技巧 职业,并培训未来的研究血液学领导者。学员拥有医学博士,医学博士/博士学位或博士学位。许多 已经完成了血液学的临床奖学金培训,但其他人是希望从事的基础研究人员 领域。通过申请过程和计划教师的访谈来选择学员。他们得到 通过与导师合作的研究经验,并获得实验室和/或临床研究的技能,数据 分析,发布论文,演示和获得独立的赠款支持。双向翻译 鼓励项目(床边和卧床床的卧床)。学员通常会获得两年的资金 从T32计划中,但经常在不同的资金机制下继续进行更长的培训,包括 K12,K23,K08或K99R00赠款和基础支持。培训进度由教师导师监视 单独的教师顾问,计划主管和血液学教师分师通过常规 研究演讲,与每个学员的会议以及书面评估。每六个月,学员更新 他们的个人发展计划(IDP),并正式呈现他们的研究进度和职业目标 研究监督委员会(ROC)由学员的导师和T32 PI组成。 100%和83% 在过去的5年和10年中完成我们计划的学员都有学术医学或 行业研究职业。该计划的优势包括:多样化的研究机会,合格的 著名的高级教师,才华横溢的初级教师的包容和指导,结构化指导 学员,包括代表性不足的少数族裔学员,强大而多样的教学会议以及长期 跨越五十年的培训毕业生的记录,随后获得学术(或行业) 研究职位并成为独立的,杰出的研究人员和思想领袖 血液学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Janis L Abkowitz其他文献

Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial.
剂量调整后的 EPOCH 加 Inotuzumab Ozogamicin 用于治疗复发或难治性 B 细胞 ALL 成人患者:1 期剂量递增试验。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    28.4
  • 作者:
    N. E. Kopmar;Kim Quach;T. Gooley;C. Martino;S. Cherian;M. Percival;A. Halpern;C. Ghiuzeli;V. Oehler;Janis L Abkowitz;Roland B Walter;R. Cassaday
  • 通讯作者:
    R. Cassaday
Structural and mechanistic insights into human choline and ethanolamine transport
对人类胆碱和乙醇胺运输的结构和机制的见解
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Keiken Ri;Tsai;Ainara Claveras Cabezudo;Wiebke Jösting;Zhang Yu;Andre Bazzone;Nancy C P Leong;Sonja Welsch;R. Doty;Gonca Gursu;Tiffany Jia Ying Lim;Sarah Luise Schmidt;Janis L Abkowitz;Gerhard Hummer;Di Wu;Long N. Nguyen;S. Safarian
  • 通讯作者:
    S. Safarian

Janis L Abkowitz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Janis L Abkowitz', 18)}}的其他基金

Deciphering the molecular mechanism of ineffective erythropoiesis in MDS-5q
破译MDS-5q无效红细胞生成的分子机制
  • 批准号:
    10773217
  • 财政年份:
    2023
  • 资助金额:
    $ 73.58万
  • 项目类别:
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
  • 批准号:
    9144794
  • 财政年份:
    2013
  • 资助金额:
    $ 73.58万
  • 项目类别:
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
  • 批准号:
    9350172
  • 财政年份:
    2013
  • 资助金额:
    $ 73.58万
  • 项目类别:
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
  • 批准号:
    8583491
  • 财政年份:
    2013
  • 资助金额:
    $ 73.58万
  • 项目类别:
Translational Studies of Inherited Marrow Failure and Myelodysplastic Syndromes
遗传性骨髓衰竭和骨髓增生异常综合征的转化研究
  • 批准号:
    8734906
  • 财政年份:
    2013
  • 资助金额:
    $ 73.58万
  • 项目类别:
Clinical and Molecular Characterization of Familial Marrow Failure Syndrome
家族性骨髓衰竭综合征的临床和分子特征
  • 批准号:
    8214798
  • 财政年份:
    2012
  • 资助金额:
    $ 73.58万
  • 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
  • 批准号:
    8257066
  • 财政年份:
    2011
  • 资助金额:
    $ 73.58万
  • 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
  • 批准号:
    8668043
  • 财政年份:
    2011
  • 资助金额:
    $ 73.58万
  • 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
  • 批准号:
    8541530
  • 财政年份:
    2011
  • 资助金额:
    $ 73.58万
  • 项目类别:
Heme trafficking and its impact on systemic iron homeostasis
血红素运输及其对全身铁稳态的影响
  • 批准号:
    8004431
  • 财政年份:
    2011
  • 资助金额:
    $ 73.58万
  • 项目类别:

相似国自然基金

CD40hiCD138hiPIR-Ahi巨噬细胞训练免疫的形成及其促进慢性排斥反应的机制研究
  • 批准号:
    82371794
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
面向底层视觉任务的通用自监督预训练基础模型研究
  • 批准号:
    62371164
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
认知原理启发的训练仿真系统战场空间表示方法研究
  • 批准号:
    62306329
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
支持深度伪造检测的精细化高效训练集生成方法研究
  • 批准号:
    62372423
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
面向大规模图预训练模型的知识迁移关键问题研究
  • 批准号:
    62376129
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Northern California Acute Care Research Consortium (NORCARES)
北加州急症护理研究联盟 (NORCARES)
  • 批准号:
    10552463
  • 财政年份:
    2023
  • 资助金额:
    $ 73.58万
  • 项目类别:
Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates
用于骨髓抽吸物实时充分性分析的深紫外显微镜
  • 批准号:
    10761397
  • 财政年份:
    2023
  • 资助金额:
    $ 73.58万
  • 项目类别:
Elucidating the role of DCAF7 on hematopoietic stem cell maintenance
阐明 DCAF7 对造血干细胞维持的作用
  • 批准号:
    10785443
  • 财政年份:
    2023
  • 资助金额:
    $ 73.58万
  • 项目类别:
TRIO Administrative Core
TRIO 行政核心
  • 批准号:
    10725471
  • 财政年份:
    2023
  • 资助金额:
    $ 73.58万
  • 项目类别:
TRIO Professional Development Core
TRIO 专业发展核心
  • 批准号:
    10725472
  • 财政年份:
    2023
  • 资助金额:
    $ 73.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了